Chemoprevention of head and neck cancer with retinoids: A negative result

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 3, 2005, Pages 198-203

  Perry, Christopher F ^a,b,f   Stevens, Maurice ^c   Rabie, Ibrahim ^d   Yarker, Mary Ellen ^c   Cochrane, Julie ^a,b   Perry, Emily ^a,b   Traficante, Robert ^e   Coman, William ^a,b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d Queensland Government   (Australia)

^e Covance Pty Ltd ^*  (Australia)

^f NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ISOTRETINOIN; LIVER ENZYME; PLACEBO; TRIACYLGLYCEROL;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; BACKACHE; BLADDER CANCER; BLEEDING; CANCER PREVENTION; CANCER RECURRENCE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; FLU LIKE SYNDROME; HEAD AND NECK CARCINOMA; HEADACHE; HUMAN; INFECTION; LIVER DYSFUNCTION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; RANDOMIZED CONTROLLED TRIAL; RASH; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOPREVENTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; NEW SOUTH WALES; POISSON DISTRIBUTION; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETINOIDS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 14844288285     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.3.198     Document Type: Article

References (17)

1. Shah JP, Strong EW, DeCosse JJ, Itri L, Sellers P. Effect of retinoids on oral leukoplakia. Am J Surg. 1983;146:466-470.
2. Hong WK, Endicott J, Itri LM, et al. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986;315:1501-1505.
3. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med. 1993;328:15-20.
4. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963-968.
5. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have had head and neck cancers: incidence, effect on survival and implications based on RTOG experience. Int J Radiat Oncol Biol Phys. 1989;17:449-456.
6. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343-1353.
7. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990;323:795-801.
8. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J Natl Cancer Inst. 2000;92:977-986.
9. Bolla M, Lefur R, Ton Van J, et al. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx: results of a multicentric double-blind randomised study. Eur J Cancer. 1994;30A:767-772.
10. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334:1145-1149.
11. Lippman SM, Lee JJ, Karp DD, et al. Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst. 2001;93:605-618.
12. Bowen DJ, Thornquist M, Anderson K, et al. Stopping the active intervention: CARET. Control Clin Trials. 2003;24:39-50.
13. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
14. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029-1035.
15. Khuri FR, Kim ES, Lee JJ, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001;10:823-829.
16. Fadlo R, Khuri MD. Isotretinoin effects in head and neck cancer recurrence and second primary tumors. In: Program and abstracts of the American Society of Clinical Oncology 39th Annual Meeting; May 31-June 3, 2003; Chicago, Ill. Abstract 359.
17. Shin DM, Khuri FR, Murphy B, et al. Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma: a novel bioadjuvant phase II trial. J Clin Oncol. 2001;19:3010-3017.